Month: November 2020

The U.S. Food and Drug Administration on Saturday authorized the emergency use of a COVID-19 antibody therapy that President Donald Trump said helped cure him of the disease caused by the coronavirus.On the same day, the Johns Hopkins Coronavirus Resource Center reported that the U.S. had passed 12 million COVID-19 cases.“It’s really a moment that we want to call on every American to increase their vigilance,” Dr. Deborah Birx, the White House coronavirus response coordinator, said this week.The Regeneron Pharmaceuticals Inc. therapy approved by the FDA is made up of the monoclonal antibodies, casirivimab and imdevimab. They are to be administered together to treat mild to moderate COVID-19 in adults, including those 65 and older with some chronic medical conditions, and children who are at high risk of a more severe case.The company expects to have enough of the treatment ready for about 200,000 patients by the first week of January.Canada’s chief public health officer, Dr. Theresa Tam, said Friday she expects the number of new daily cases to reach 20,000 per day, up from just under 5,000 per day currently, if Canadians maintain their current number of personal contacts.However, she warned that number could spike to 60,000 a day by the end of December if Canadians increase their level of contact with other people, a possible scenario with the Christmas holiday season looming.Canadian Prime Minister Justin Trudeau has called on Canadians to stay home and follow public health rules to help slow the spread of COVID-19.Friday, U.S. pharmaceutical company …

As coronavirus cases surge globally, the COVID-19 deaths of two senior Serbian Orthodox Church clerics — one who died weeks after presiding over the funeral of the other — are raising questions about whether some religious institutions are doing enough to slow the spread of the virus.More reports are emerging about people who attended religious services and contract the virus — some after parishioners seemed to ignore the pleas of church and health officials to wear masks, practice social distancing and other steps to combat the virus that’s killed nearly 1.4 million people worldwide.In Belgrade, many mourners paying their respects Saturday to Serbian Orthodox Church Patriarch Irinej ignored precautions, and some kissed the glass shield covering the patriarch’s body, despite warnings not to do so from Serbia’s epidemiologists.That scene unfolded three weeks after the 90-year-old Irinej led prayers at the funeral of Bishop Amfilohije in nearby Montenegro, an event attended by thousands, where many kissed the bishop’s remains in an open casket.The highly publicized episodes happened as Serbia reported thousands of newly confirmed infections daily in the country of 7 million and as the government in recent days has tightened measures to hold off the virus. As the country’s health system strains to treat more and more people for the virus, some patients in Belgrade hospitals with less serious conditions are being transferred to hospitals elsewhere.Those same kinds of tough decisions and terrible predicaments are playing out across the United States.California enacts a nighttime curfew starting Saturday night to try …

More than 15 million people in Europe have been infected with coronavirus, making it the worst-hit region in the world.  Authorities hope new lockdowns will get the situation under control.  More with VOA Correspondent Mariama Diallo. …

Trying to close out major unfinished business, the Trump administration issued regulations Friday that could lower the prices Americans pay for many prescription drugs.But in a time of political uncertainty, it’s hard to say whether the rules will withstand expected legal challenges from the pharmaceutical industry or whether President-elect Joe Biden’s administration will accept, amend or try to roll them back entirely.”The drug companies don’t like me too much. But we had to do it,” President Donald Trump said in announcing the new policy at the White House. “I just hope they keep it. I hope they have the courage to keep it,” he added, in an apparent reference to the incoming Biden administration, while noting the opposition from drug company lobbyists.The two finalized rules, long in the making, would:— Tie what Medicare pays for medications administered in a doctor’s office to the lowest price paid among a group of other economically advanced countries. That’s called the “most favored nation” approach. It is adamantly opposed by critics aligned with the pharmaceutical industry, who liken it to socialism. The administration estimates it could save $28 billion over seven years for Medicare recipients through lower copays. It would take effect January 1. — Require drugmakers, for brand-name pharmacy medications, to give Medicare enrollees rebates that now go to insurers and middlemen called pharmacy benefit managers. Insurers that deliver Medicare’s Part D prescription benefit say that would raise premiums. The nonpartisan Congressional Budget Office estimates it would increase taxpayer costs by $177 billion over …

The World Health Organization (WHO) Friday said more COVID-19 cases have been reported worldwide in the last four weeks than in the first six months of the pandemic. In his regular news briefing from WHO headquarters in Geneva, Director-General Tedros Adhanom Ghebreyesus said hospitals and intensive care units are filling up or full across Europe and the United States. Tedros said it was good news this week that at least two vaccine candidates have shown to be effective in tests and one is near emergency approval and provides hope. But he stressed that people must continue to use the tools currently available to interrupt the chains of transmission and save lives. Medical staff members wait for citizens to be tested for coronavirus at a school gym that was set up as a testing facility in Bolzano, northern Italy, Nov. 20, 2020.The WHO director-general also introduced a new report published by the U.N. agency on antimicrobial resistance (AMR) in the world and ways to better control it. Antimicrobials include antibiotics and antivirals used in humans and animals, and pesticides used in agriculture. The WHO said their misuse or overuse can lead to bacteria, viruses, fungi and parasites developing a resistance to them over time, making medicines ineffective and infections harder to treat, and increasing the risk of disease spread, severe illness and death. Microorganisms that develop AMR are sometimes referred to as “superbugs.” Tedros said the COVID-19 pandemic is a stark reminder of the intimate relationship between humans, animals and the environment.He said AMR may not …

The World Health Organization says the antiviral drug remdesivir is not beneficial and should not be used in treating patients hospitalized with COVID-19.   A WHO panel of international experts who reviewed the results of clinical trials have concluded there currently is no evidence that remdesivir improves survival of COVID-19 patients, no matter how severely ill they are.      Janet Diaz, head of Clinical Care at the World Health Organization,  says the panel conditionally recommends against the use of remdesivir in hospitalized COVID-19 patients regardless of the severity of their illness. The panel says the evidence shows the drug has possibly no effect on mortality.   “Now, this does not prove that remdesivir does not have a benefit at all. That is why it is a conditional recommendation. There can still be potential small benefit maybe in a health sub-group, which is why the panel also recommended continued trials, continued enrollment into clinical trials,” Diaz said.   She suggested it might perhaps be better to focus on sub-groups, such as severe patients versus critical patients in future clinical trials.      The WHO panel’s recommendation is based on new evidence, which compared the effects of several drug treatments for COVID-19.  It includes data from four international randomized trials involving more than 7,000 patients hospitalized for COVID-19.   Bram Rochwerg, a practicing ICU doctor in Hamilton, Ontario, Canada, and co-chair of the WHO panel, told VOA there is still ongoing uncertainty about the impact of remdesivir on survivability and mortality. …

Pharmaceutical company Pfizer and its German partner, BioNTech, said Friday they have filed for emergency authorization from the U.S. Food and Drug Administration (FDA) to use their COVID-19 vaccine, saying they are poised to begin distribution within hours after authorization. The application comes after the companies said testing shows the vaccine has an effectiveness rate of 95 percent, with no serious safety concerns observed to date. In a news release, the companies say in addition to their submission to the FDA, they are seeking authorization from authorities in Australia, Canada, Europe, Japan and the U.K., and plan to submit applications immediately to other regulatory agencies around the world. FILE – A worker passes a line of freezers holding coronavirus disease vaccine candidate BNT162b2 at a Pfizer facility in Puurs, Belgium, in an undated photograph.With the COVID-19 pandemic surging around the world, the regulators will be under pressure to make a quick decision on the vaccine. In an interview, former U.S. FDA chief scientist Jesse Goodman explained the standard for emergency use authorization only requires that a product “may be effective.” He said the agency performs an assessment on whether the available data determines if the potential benefits outweigh the potential risks. During a White House briefing Thursday, the leading U.S. infectious disease expert, Dr. Anthony Fauci, said he understands that people might be concerned about the speed with which these vaccines have been developed, but he expressed confidence that the vaccines will be safe. “The process of the speed did not compromise at all safety, nor did …

The U.S. space agency, NASA, in collaboration with the European Space Agency (ESA), is set to launch a satellite Saturday designed to monitor rising sea levels, the latest in a series of orbiting spacecraft monitoring the status of the world’s oceans.   NASA says the satellite, called the Sentinel-6 Michael Freilich, is scheduled to launch from Vandenberg Air Force Base in central California early Saturday.  Named after former NASA Earth Science Division Director Michael Freilich, the U.S.-European satellite will be carried into space on a SpaceX Falcon 9 rocket.   The Sentinel-6 is about the size of a small pickup truck, and it will measure sea-surface height, wave-height and windspeed, allowing scientists to monitor changes in sea levels caused by climate change.     The data that it collects on sea level variations near coastlines will provide information to support coastal management and with planning for floods, while its atmospheric measurements will enhance weather and hurricane forecasts.   NASA Sentinel 6 mission scientist Craig Donlon says the data gathered by the craft will be used alongside information provided by previous Sentinel satellites to build a more complete a picture of the oceans.     “Sentinel-3 is providing the sea surface temperature and the ocean biology measurements. Sentinel-1 is providing radar imaging measurements of ocean swell waves, of sea ice. Sentinel-2 provides high resolution measurements in the coastal zone,” Donlon said.   Unlike previous Earth observation missions, the Sentinel-6 observatory will collect measurements at a much higher resolution and be able …

The Pentagon has confirmed that acting Undersecretary of Defense for Policy Anthony Tata has COVID-19.   Tata and several other people were exposed to the virus, the Pentagon said, after meeting with a Lithuanian delegation, including Defense Minister Raimundas Karoblis, who has tested positive for COVID.”Mr. Tata was tested today and has tested positive for COVID-19 on two successive tests.  He will isolate at home for the next 14 days in accordance with Center for Disease Control protocols,” a Pentagon statement said. Further contact tracing is being done of Defense Department officials who may have had contact with Tata and the Lithuanian delegation, the statement said.  FILE – Travelers wait in the boarding area for trains during the Thanksgiving holiday travel rush at Pennsylvania Station in New York, Nov. 27, 2019.CDC discourages Thanksgiving travel Coronavirus infections is the United States are exploding toward the 12 million mark. At 11.7 million cases, the U.S. has more COVID-19 cases than anyplace else.  The U.S. also has the world’s largest coronavirus death toll, with more than a quarter of a million fatalities.The U.S. Centers for Disease Control and Prevention and an alliance of three professional medical groups released separate statements Thursday urging Americans to stay home for next week’s Thanksgiving celebrations and to rethink their observations of the holiday. They are afraid coronavirus cases and deaths could jump higher if Americans do not scale back their traditional Thanksgiving plans.“Positive cases spiked after Memorial Day, after the Fourth of July, after Labor Day, and now – two weeks after Halloween,” the American Hospital Association, the American Medical Association, and the American Nurses Association said in a joint open letter. “The record-shattering surge underway is resulting in uncontrolled community spread and infection that has already overburdened …

Activists in Cameroon held events and marches for Thursday’s World Toilet Day, calling on authorities to provide more public bathrooms. Cameroonian authorities say 60% of its 25 million people lack toilets, fueling the spread of diseases such as cholera and dysentery.School authorities at Yaoundé’s Government Primary School Efoulan say they have close to 2,000 children and teachers but only five toilets, which are often unusable as they run short of water and toilet paper.The Cameroon Association to Improve Hygiene organized this and similar events in 30 schools in the capital to mark this year’s World Toilet Day.The group’s head, Edmond Kimbi, said hundreds of their members also marched in Yaoundé and coastal cities to demand more and better public toilets.”It is actually too regrettable that schools and universities have very few toilets, which lack water and are always dirty,” he said. “It is worse when you visit markets, where thousands of people visit the markets each day. The consequences of this is that nearby bushes and dark corners are being transformed into toilets, thereby making our towns always dirty.”Public toilets in Douala, Cameroon, Nov. 19, 2020. (Moki Edwin Kindzeka/VOA)Authorities say a September outbreak of cholera, a bacterial disease spread through dirty water, in the port cities of Douala and Kribi killed at least 90 people.Dr. Sintieh Ngek, a medical officer with the Cameroon Baptist Convention, said the lack of toilets is spreading disease.”Waterborne and water-based diseases like cholera, like diarrheal diseases, will be more present, and it is worth noting …

The National Science Foundation announced Thursday that it would close the huge telescope at the renowned Arecibo Observatory in Puerto Rico in a blow to scientists worldwide who depend on it to search for planets, asteroids and extraterrestrial life. The independent, federally funded agency said it was too dangerous to keep operating the single-dish radio telescope — one of the world’s largest — given the significant damage it recently sustained. An auxiliary cable broke in August, tearing a 100-foot hole in the reflector dish and damaging the dome above it. Then on November 6, one of the telescope’s main steel cables snapped, leading officials to warn that the entire structure could collapse. NSF officials noted that even if crews were to repair all the damage, engineers found the structure would still be unstable in the long term. The main entrance of the Arecibo Observatory is seen in Arecibo, Puerto Rico, Nov. 19, 2020.”This decision is not an easy one for NSF to make, but the safety of people is our No. 1 priority,” said Sean Jones, the agency’s assistant director for the Mathematical and Physical Sciences Directorate. “We understand how much Arecibo means to this community and to Puerto Rico.” He said the goal was to preserve the telescope without placing people at risk, but “we have found no path forward to allow us to do so safely.” The telescope was built in the 1960s with money from the Defense Department amid a push to develop anti-ballistic missile defenses. In its 57 years of operation, it endured hurricanes, endless …

Just as the coronavirus pandemic began to take hold, in February, four people set sail for one of the most remote places on Earth – a small camp on Kure Atoll, at the edge of the uninhabited Northwestern Hawaiian Islands.There, more than 1,400 miles from Honolulu, they lived in isolation for eight months while working to restore the island’s environment. Cut off from the rest of the planet, their world was limited to a tiny patch of sand halfway between the U.S. mainland and Asia. With no television or internet access, their only information came from satellite text messages and occasional emails.Now they are back, emerging into a changed society that might feel as foreign today as island isolation did in March. They must adjust to wearing face masks, staying indoors and seeing friends without giving hugs or hearty handshakes.”I’ve never seen anything like this, but I started reading the book The Stand by Stephen King, which is about a disease outbreak, and I was thinking, ‘Oh my goodness, is this what it’s going to be like to go home?’” said Charlie Thomas, one of the four island workers.The group was part of an effort by the state of Hawaii to maintain the fragile island ecosystem on Kure, which is part of the Papahanaumokuakea Marine National Monument, the nation’s largest contiguous protected environment. The public is not allowed to land anywhere in the Northwestern Hawaiian Islands.Charlie Thomas, of Auckland, New Zealand, describes what her camp was like on Kure Atoll …

Thursday brought further good news from the global effort to produce a safe and effective vaccine against the coronavirus that causes COVID-19.  A report published in the prestigious medical journal The Lancet says that a potential vaccine developed by British pharmaceutical giant AstraZeneca in collaboration with the University of Oxford was safe and produced a strong immune response in both younger and older participants.  The two-dose vaccine was given to 560 healthy adult volunteers in a second-stage clinical trial, including 240 volunteers 70 years of age and older.  Dr. Maheshi Ramasamy, a  University of Oxford researcher and co-author of the study, described the antibody and T-cell responses in the older volunteers as “robust.”  Pfizer Says Its Coronavirus Vaccine is 95% EffectivePfizer to seek approval within days for emergency use of vaccine COVID-19 poses the greatest risk for older adults and people with preexisting health conditions.  “We hope that this means our vaccine will help protect some of the most vulnerable people in society,” Ramasamy said, but he noted that further research still needs to be conducted.  The vaccine is currently undergoing final late-stage global clinical trials to prove its ultimate safety and efficacy.  The data from the Oxford-AstraZeneca Phase 2 trial comes as two U.S.-based  pharmaceutical companies report their COVID-19 vaccines are more than 90% effective against the virus.  Pfizer announced Wednesday that it will seek emergency approval for the vaccine it has developed in collaboration with Germany’s BioNTech. Moderna announced earlier this week that its vaccine is nearly 95% effective after an …

As the deadly coronavirus continues to rage across the U.S. and around the world, people are turning to COVID-19-related apps to figure out their day-to-day risks. VOA’s Julie Taboh has more. Producers: Julie Taboh, Adam Greenbaum …

India’s capital, New Delhi, is battling twin health emergencies, as it copes with deadly air pollution that spikes in winter months and a record surge in coronavirus cases. Doctors say the city’s fight against the pandemic has become harder as the toxic air makes the city more vulnerable to the virus. Anjana Pasricha reports.Videographer:  P Pallavi, Producer: Henry Hernandez …

The head of Germany’s disease control agency said Thursday that while the coronavirus infection rate in the country remains serious, there are signs a partial lockdown is working.Germany implemented restrictive measures in early November to curb a nationwide surge in cases, closing bars, restaurants and other leisure venues but keeping schools and shops open.Speaking to reporters in Berlin, Robert Koch Institute chief Lothar Wieler said the number of new infections has since plateaued, with 22,609 reported on Thursday – roughly the same number as a week ago. He said the fact they are not rising is good news but cautioned that it was too early to say if this is a trend.Wieler said the overall number of cases is still too high, and there is a risk that hospitals may become overwhelmed. Wieler, however, also expressed optimism the numbers will start to go down now that they have stabilized.Wieler also said the news this week that at least two potential vaccines are showing better than 90 percent effectiveness was “extremely encouraging.” He said, “I know if the vaccines have an efficacy of more than 90% then they would be great weapons. That’s great.”Wieler said it was unclear how long the restrictions would remain in place. When they were implemented, Chancellor Angela Merkel said the plan was for them to run through November, in hopes the nation would be able to lift some of them in time for the Christmas holiday in December.The Robert Koch Institute reports Germany now has seen …

COVID-19 cases are surging to record highs in India’s capital, New Delhi, even as they drop sharply in the rest of the country.Moreover, doctors say the pandemic is extracting a heavier toll in the city as air pollution levels spike dangerously, making its 20 million residents more vulnerable to the virus.  Large numbers of people, many without masks, packing markets and celebratory gatherings during the recent Hindu festive season have also raised concerns about the spread of the infection.Authorities are flying in doctors and paramedics, increasing the number of intensive care beds, and ramping up testing and tracing as the twin health emergencies overwhelm hospitals.Sorry, but your browser cannot support embedded video of this type, you can People walk near India Gate on a smoggy afternoon in New Delhi, India, Nov. 15, 2020.Authorities acknowledge that the city’s hazardous air poses a risk to the city during the pandemic.“Pollution is coming. The sky is filled with smoke and this is worsening the situation with coronavirus,” Delhi’s chief minister, Arvind Kejriwal, said this month as he launched a campaign to control pollution levels that included measures such as spraying water to control dust levels.Delhi has now counted over half a million cases out of the nearly 9 million in India, the world’s second-worst affected nation.As the city witnesses its worst phase of the pandemic, authorities have lowered the number of people allowed at marriage ceremonies from 200 to 50,and are considering shutting down markets in areas that are emerging as COVID-19 hotspots.“The …

Thursday brought further good news from the global effort to produce a safe and effective vaccine against the coronavirus that causes COVID-19.  A report published in the prestigious medical journal The Lancet says that a potential vaccine developed by British pharmaceutical giant AstraZeneca in collaboration with the University of Oxford was safe and produced a strong immune response in both younger and older participants.  The two-dose vaccine was given to 560 healthy adult volunteers in a second-stage clinical trial, including 240 volunteers 70 years of age and older.  Dr. Maheshi Ramasamy, a  University of Oxford researcher and co-author of the study, described the antibody and T-cell responses in the older volunteers as “robust.”  Pfizer Says Its Coronavirus Vaccine is 95% EffectivePfizer to seek approval within days for emergency use of vaccine COVID-19 poses the greatest risk for older adults and people with preexisting health conditions.  “We hope that this means our vaccine will help protect some of the most vulnerable people in society,” Ramasamy said, but he noted that further research still needs to be conducted.  The vaccine is currently undergoing final late-stage global clinical trials to prove its ultimate safety and efficacy.  The data from the Oxford-AstraZeneca Phase 2 trial comes as two U.S.-based  pharmaceutical companies report their COVID-19 vaccines are more than 90% effective against the virus.  Pfizer announced Wednesday that it will seek emergency approval for the vaccine it has developed in collaboration with Germany’s BioNTech. Moderna announced earlier this week that its vaccine is nearly 95% effective after an …

As the deadly coronavirus continues to rage across the U.S. and around the world, people are turning to COVID-19-related apps to figure out their day-to-day risks. VOA’s Julie Taboh has more. Producers: Julie Taboh, Adam Greenbaum …

The United States has surpassed 250,000 coronavirus deaths as new cases surge in many parts of the country.New York City on Wednesday announced the closure of its school system, the nation’s largest, with the city recording a seventh consecutive day with a COVID-19 positivity rate above 3%.“Public school buildings will be closed as of tomorrow, Thursday Nov. 19, out [of] an abundance of caution. We must fight back the second wave of COVID-19,” New York City Mayor Bill de Blasio wrote on Twitter.New York City has reached the 3% testing positivity 7-day average threshold. Unfortunately, this means public school buildings will be closed as of tomorrow, Thursday Nov. 19, out an abundance of caution. We must fight back the second wave of COVID-19.— Mayor Bill de Blasio (@NYCMayor) November 18, 2020In-person school resumed for New York children between late September and early October, when the seven-day positivity rate was under 2%.Other major cities, including Boston and Detroit, have made recent moves to halt in-person classes for their schools.Across the United States there have been more than 11.5 million confirmed cases since the pandemic began.The current wave of infections is adding to that number at an increased rate with an average of nearly 160,000 new cases each day during the past week. That is about triple the number of new daily cases in the United States one month ago. More than 1,100 people are dying per day.Health care workers are dealing with the strain of a record number of hospitalized COVID-19 patients.The …

The World Health Organization’s emergencies program director said Wednesday that vaccines alone would not end the COVID-19 pandemic and would do nothing to stop the current global surge in coronavirus infections.Mike Ryan made the comments during a virtual question-and-answer session from the agency’s headquarters in Geneva.His comments came the same day that pharmaceutical company Pfizer and its German partner BioNTech announced that final results from the late-stage trial of their COVID-19 vaccine showed it was 95% effective.The companies said they had the required two months of safety data and would apply for emergency U.S. authorization within days.On Monday, Moderna released preliminary data for its vaccine, showing similar effectiveness.Ryan said the world would have to get through this current wave of COVID-19 infections without vaccines, which he said were not the total answer.”Some people think that vaccines will be, in a sense, the solution, the unicorn we’ve all been chasing. It’s not,” he said.He said the most important thing people could do now to keep hospitals and intensive care units from overflowing was to stop the spread of the disease through physical distancing measures. Once a viable vaccine is widely available, he said, it will be another tool that can be used.”Adding vaccines is going to give us a huge chance. But if we add vaccines and forget the other things, COVID does not go to zero,” Ryan said. “We need to add vaccination to the existing physical measures” to taking care and practicing good hygiene.  “And if we add that …

Thousands of demonstrators rallied Wednesday in central Berlin to protest the parliamentary vote that would give Chancellor Angela Merkel’s government powers to enforce restrictions aimed at curbing the spread of COVID-19.Germany’s lower and upper houses of parliament are due to vote and pass laws Wednesday that could allow the government to impose restrictions on social contact, rules on mask-wearing, drinking alcohol in public, shutting shops and stopping sports events.   Although most Germans accept the latest limited lockdown to tackle a second wave of the virus, a minority of right-wing critics say the law gives the government too much power. The far-right Alternative for Germany (AfD) has even compared the measures to the Enabling Act of 1933 that paved the way Hitler’s Nazi dictatorship.  Germany Sees Signs for Cautious Optimism in COVID-19 Cases Infectious-disease expert says while new numbers are still high, the infection rate is down Berlin police, bolstered by forces from around the country, cordoned off a wide perimeter around the capital’s government center, and a series of protests planned outside of Germany’s Bundestag parliament building were banned due to security concerns.   At one point, security officers used a water cannon to subdue protesters and keep them away from the parliament building.     One protester wore a face mask with the words “Merkel-Muzzle,” others held banners with slogans such as “For Enlightenment. Peace and Freedom.” But most protesters were neither wearing masks nor socially distanced.     Germany, Europe’s largest economy, was widely praised for keeping …

The World Health Organization has officially declared an end to the Ebola outbreak in Democratic Republic of Congo’s Equateur Province, nearly six months after the first cases were reported. Health officials are hailing the end of this outbreak as a milestone and cause for celebration.  Combating Ebola in the remote, heavily forested region posed numerous logistical challenges, not least of which was reaching communities scattered across this geographically vast area and then gaining their trust.Bob Ghosn is head of the International Federation of Red Cross and Red Crescent Societies Ebola Response Operation in the DRC   Speaking on a telephone line from Goma, he tells VOA tackling Ebola in itself is difficult enough.   But tackling two epidemics, Ebola and COVID-19, at the same time has proven to be a nightmare.“It also made the supply chain for Ebola response much more difficult because everything slowed down, borders have closed,” Ghosn said.  “There obviously were requests from all countries in the world for PPE equipment that was needed here.  So, that made things more difficult and last, but not least, the economic impact of COVID-19 is mind boggling in a country like DRC.” Equateur province, DRCThis was the third Ebola outbreak in DRC in the last three years.   It came just as another more serious epidemic in North Kivu province was winding down.  That epidemic, which lasted nearly two years, infected more than 3,400 people, killing nearly 2,300.  By comparison, the final toll in Equateur Province was 119 cases, including 55 deaths.  Ghosn says everyone in …

The pharmaceutical company Pfizer said Wednesday that its coronavirus vaccine is 95% effective and caused no serious side effects as it plans to seek federal approval for the vaccine’s emergency use.Pfizer disclosed the results after a final analysis of the vaccine’s Phase 3 trial, which also revealed it protects older people most at risk of dying from COVID-19, the disease caused by the coronavirus.The American pharmaceutical giant’s announcement came a week after it first revealed promising preliminary findings, and days before it plans to formally ask the federal government to approve the vaccine for emergency use.5 Things to Know About Pfizer’s Coronavirus Vaccine Early results look great, but questions remain Pfizer has not yet released detailed information about the trial and the results have not been scrutinized by independent experts.Pfizer and BioNTech, a German biotechnology company that partnered with Pfizer on the vaccine’s development, said they plan to produce up to 50 million doses worldwide this year and up to 1.3 billion in 2021. Pfizer also said it would submit the results of the trial to other regulatory agencies around the world.The biotechnology company Moderna, Inc., said earlier this week that an interim analysis of its late-stage study revealed its experimental vaccine appears to be 94.5% effective.The U.S. government has said it hopes Moderna and Pfizer will produce some 20 million doses for distribution in December, with the first doses offered to vulnerable people like health care workers and those with serious health conditions. …